Methods: The prospective, descriptive cross-sectional study was conducted on 54 patients with 59 BI-RADS 4 nonpalpable breast lesions, histiopathologic results were compared with US features at the Ho Chi Minh city Oncology Hospital from May 2018 to July 2019.